Sharon Kredo Russo - 29 Jul 2026 Form 4 Insider Report for COMPUGEN LTD (CGEN)

Reporting relationship: SVP, Research & Discovery
Issuer ticker: CGEN
Reported as of: 29 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 30 Jul 2026, 16:06:41 UTC
Prior SEC filing: 18 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Sharon Kredo Russo

Key filing fact

Sharon Kredo Russo filed Form 4 for COMPUGEN LTD (CGEN) on 30 Jul 2026.

Key facts

This page summarizes Sharon Kredo Russo's Form 4 filing for COMPUGEN LTD (CGEN).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 30 Jul 2026, 16:06.

Change

Previous filing in this sequence was filed on 18 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002116341 Primary reporting owner

Kredo Russo Sharon

Relationship: SVP, Research & Discovery
Address: C/O COMPUGEN LTD., 26 HAROKMIM STREET, HOLON, ISRAEL
Signature: /s/ Sharon Kredo Russo
Signature date: 30 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CGEN transaction

Ordinary Shares

Award

Transaction value
Shares: +18,000
Change %: +92%
Price: $0.000000^*
Shares after: 37,500
Date: 29 Jul 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CGEN transaction Derivative

Share Option (right to buy)

Award

Transaction value
Shares: +24,000
Change %
Price: $0.000000^*
Shares after: 24,000
Date: 29 Jul 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 24,000
Exercise price: $2.26
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents a restricted stock unit ("RSU") award. The RSUs vest 25% on September 30, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.

Footnote F2

This option vests 25% on September 30, 2027 and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.